Hedge Fund - RA Capital Management

Peter Kolchinsky's Ra Capital Management has recently sold a total of 300,000 shares of Derma Sciences Inc (NASDAQ:DSCI).

Peter Kolchinsky's hedge fund, Ra Capital Management disclosed upping its position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) some more.

Peter Kolchinsky's, RA Capital Management solidified its position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) even more today.

Since the beginning of November, Peter Kolchinsky's RA Capital Management has informed the U.S.

As we approach the nexus of third quarter 13F filings (next week), hedge funds have been very active in 13D and 13G land.

Peter Kolchinsky's Ra Capital Management surged its position in Dynavax Technologies Corporation (NASDAQ:DVAX) to almost 26 million shares, a new filing with the SEC has revealed.

Peter Kolchinsky, Achillion Pharmaceuticals: This afternoon, Peter Kolchinsky and his hedge fund, RA Capital Management, strengthened their position in Achillion Pharmaceuticals, Inc.

 Outerwall, Pandora, Achillion, hedge funds: It’s no secret that at Insider Monkey, we track hedge funds (discover why here).

Here are the eleven most important moves made in the hedge fund world this week. Bill Ackman reduced his Herbalife short significantly, replacing it with long-term put options. Dan Loeb ups his activist campaign at Sotheby’s, snatching 9.